Pakianathan Deepika
Theravance Biopharma, Inc. · Director
Pakianathan Deepika is listed in filings as Director at Theravance Biopharma, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2026, including sale activity. Recent filings connect the profile to Theravance Biopharma, Inc. (TBPH), Mereo BioPharma Group plc (MREO), and Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Aug 23, 2024 to Jun 16, 2026. Reported amounts are shown as $222.9K to $466.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $466k105.2k shares | SellAug 22, 2024 | $4.43 | $0.3146 |